Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment-refractory anxiety; definition, risk factors, and treatment challenges
Peter Roy‐Byrne
Dialogues in Clinical Neuroscience (2015) Vol. 17, Iss. 2, pp. 191-206
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Amir Garakani, James W. Murrough, Rafael C. Freire, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 310
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 206
Modeling Trait Anxiety: From Computational Processes to Personality
James G. Raymond, J. Douglas Steele, Peggy Seriès
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 198
The Utility of Event-Related Potentials in Clinical Psychology
Greg Hajcak, Julia Klawohn, Alexandria Meyer
Annual Review of Clinical Psychology (2019) Vol. 15, Iss. 1, pp. 71-95
Closed Access | Times Cited: 180
The Neuropsychology of Anxiety
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024)
Closed Access | Times Cited: 73
Ketamine treatment for refractory anxiety: A systematic review
Jamie L. Tully, Amelia D. Dahlén, Connor J. Haggarty, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 10, pp. 4412-4426
Open Access | Times Cited: 62
Social isolation induces neuroinflammation and microglia overactivation, while dihydromyricetin prevents and improves them
Alzahra J. Al Omran, Amy S. Shao, Saki Watanabe, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 52
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
The definition of treatment resistance in anxiety disorders: a Delphi method‐based consensus guideline
Katharina Domschke, Patrik D. Seuling, Miriam A. Schiele, et al.
World Psychiatry (2024) Vol. 23, Iss. 1, pp. 113-123
Open Access | Times Cited: 13
Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review
Wicher A. Bokma, Guido A. A. M. Wetzer, Jurriaan B. Gehrels, et al.
Depression and Anxiety (2019) Vol. 36, Iss. 9, pp. 801-812
Open Access | Times Cited: 58
Cellular mechanisms and molecular signaling pathways in stress-induced anxiety, depression, and blood–brain barrier inflammation and leakage
Menizibeya O. Welcome
Inflammopharmacology (2020) Vol. 28, Iss. 3, pp. 643-665
Closed Access | Times Cited: 56
Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature
Michael D. Banov, Jonathan R. Young, Tyler Dunn, et al.
CNS Spectrums (2019) Vol. 25, Iss. 3, pp. 331-342
Closed Access | Times Cited: 55
What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications
Adele Framer
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 55
The emerging role of psilocybin and MDMA in the treatment of mental illness
Hartej Gill, Barjot Gill, David Chen‐Li, et al.
Expert Review of Neurotherapeutics (2020) Vol. 20, Iss. 12, pp. 1263-1273
Closed Access | Times Cited: 54
Right frontal anxiolytic-sensitive EEG ‘theta’ rhythm in the stop-signal task is a theory-based anxiety disorder biomarker
Shabah M. Shadli, Lynne C. Ando, Julia A. McIntosh, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 49
Anxiety Assessment in Polish Students during the Russian–Ukrainian War
Edyta Skwirczyńska, Mateusz Kozłowski, Katarzyna Nowak, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 20, pp. 13284-13284
Open Access | Times Cited: 30
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions
Harry Fagan, David S. Baldwin
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 6, pp. 535-548
Open Access | Times Cited: 22
Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs
K. Roseberry, H Le-Niculescu, Daniel F. Levey, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2894-2912
Open Access | Times Cited: 17
Mechanisms underlying the early risk to develop anxiety and depression: A translational approach
Ned H. Kalin
European Neuropsychopharmacology (2017) Vol. 27, Iss. 6, pp. 543-553
Open Access | Times Cited: 51
Nutrition as Metabolic Treatment for Anxiety
Nicholas G. Norwitz, Uma Naidoo
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 38
Between Action and Emotional Survival During the COVID-19 era: Sensorimotor Pathways as Control Systems of Transdiagnostic Anxiety-Related Intolerance to Uncertainty
Sari Goldstein Ferber, Gal Shoval, Gil Zalsman, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 38
Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders
Elizabeth Whittaker, Alisher R. Dadabayev, Sonalee Joshi, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 37
Towards a precision psychiatry approach to anxiety disorders with ecological momentary assessment: the example of panic disorder
Donald J. Robinaugh, Mackenzie Brown, Olivia M Losiewicz, et al.
General Psychiatry (2020) Vol. 33, Iss. 1, pp. e100161-e100161
Open Access | Times Cited: 35
Associations between urinary heavy metals and anxiety among adults in the National Health and Nutrition Examination Survey (NHANES), 2007–2012
Jianxiong Gui, Ran Ding, Dishu Huang, et al.
Chemosphere (2023) Vol. 341, pp. 140085-140085
Closed Access | Times Cited: 12
An Evaluation of Impostor Phenomenon in Data Science Students
Lindsay R. Duncan, Gita Taasoobshirazi, Ashana Vaudreuil, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4115-4115
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top